The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-platelet


Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to determine whether Plasma Factor VIII Levels are related to the treatment of bleeding in ischemic stroke(IS).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 May 2017.

1 May 2016 5 Feb 2016 1 Jan 2018 1 Aug 2021 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample